 BRIDGEWATER, N.J., May 10, 2021 PRNewswire Insmed Incorporated Nasdaq: INSM announced today that it intends to offer and sell 250 million of its common stock the Shares and 500 million aggregate principal amount of its convertible senior notes due 2028 the Notes in separate concurrent underwritten public offerings, a portion of which will be used to repurchase Insmeds existing outstanding convertible senior notes due 2025. 